A Single- and Multiple-Ascending Dose Study of SRK-439 in Healthy Adults
Phase 1
18–55
1 site in OH
About this study
This Phase 1 study is focused on people with healthy volunteers. The primary outcome being measured is Evaluate the safety and tolerability of single and multiple SRK-439 SC dose administration in healthy adult participants.
Based on ClinicalTrials.gov records.
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Primary: Evaluate the safety and tolerability of single and multiple SRK-439 SC dose administration in healthy adult participants
Secondary: Evaluate the PD of single and multiple SRK-439 SC dose administration in healthy adult participants, Evaluate the PK of single and multiple SRK-439 SC dose administration in healthy adult participants